Epilepsy is one of the most common neurological disorders in childhood, affecting nearly 0.5-1% of children worldwide. The management of pediatric epilepsy has seen substantial progress in recent years, thanks to advances in genetics, neuroimaging, and pharmacology. This article explores some of the latest developments in the pharmacological management of pediatric epilepsy.
HTML PDFShare this article
Epilepsy Journal received 41 citations as per Google Scholar report
